|
【结 构 式】 
|
【分子编号】14853 【品名】methyl 3-piperazinophenyl ether; 1-(3-methoxyphenyl)piperazine 【CA登记号】16015-71-7 |
【 分 子 式 】C11H16N2O 【 分 子 量 】192.26092 【元素组成】C 68.72% H 8.39% N 14.57% O 8.32% |
合成路线1
该中间体在本合成路线中的序号：(VII)Alkylation of 4,6-dimethyl-7-hydroxy-1-indanone (I) with methyliodide and sodium hydride in DMF affords 7-methoxy-2,2,4,6-tetramethyl-1-indanone (II), which is demethylated with aluminum chloride in CH3CN to give 7-hydroxy-2,2,4,6-tetramethyl-1-indanone (III). Oxime formation with hydroxylamine hydrochloride in pyridine yields 7-hydroxy-2,2,4,6-tetramethyl-1-indanone oxime (IV), which on treatment with hydrogen in the presence of platinum oxide in acetic acid gives 1-amino-7-hydroxy-2,2,4,6-tetramethylindan (V) (1, 3). Acetylation of (V) with chloroacetyl chloride and triethylamine gives 2-chloro-N-(7-hydroxy-2,2,4,6-tetramethylindan-1-yl)acetamide (VI), which is finally condensed with 1-(3-methoxyphenyl)piperazine (VII) in acetonitrile.
| 【1】 Oshiro, Y.; Ueda, H.; Nakagawa, K. (Otsuka Pharmaceutical Co., Ltd.); 2,3-Dihydro-1H-indene derivs., a process for preparing them and pharmaceutical compsns. containing same. EP 0173331; ES 8800121; ES 8800884; ES 8801180; JP 1986069747; JP 1987129258; JP 1993004950; US 4788130; US 4895847; US 5242919 . |
| 【2】 Oshiro, Y.; Tottori, K.; Tanaka, T.; Kikuchi, T.; Sakurai, Y.; Ueda, H.; Novel cerebroprotective agents with central nervous system stimulating activity. 1. Synthesis and pharmacology of 1-amino-7-hydroxyindan derivatives. J Med Chem 1991, 34, 7, 2004-13. |
| 【3】 Mealy, N.; Prous, J.; Castaner, J.; OPC-14117. Drugs Fut 1993, 18, 8, 707. |
| 【4】 Tottori, K.; Tanaka, T.; Hirose, T.; Sakurai, Y.; Kikuchi, T.; Oshiro, Y.; Novel cerebroprotective agents with central nervous system stimulating activity. 2. Synthesis and pharmacology of the 1-(acylamino)-7-hydroxyindan derivatives. J Med Chem 1991, 34, 7, 2014-23. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 14847 | 7-hydroxy-4,6-dimethyl-1-indanone | C11H12O2 | 详情 | 详情 | |
| (II) | 14848 | 7-methoxy-2,2,4,6-tetramethyl-1-indanone | C14H18O2 | 详情 | 详情 | |
| (III) | 14849 | 7-hydroxy-2,2,4,6-tetramethyl-1-indanone | C13H16O2 | 详情 | 详情 | |
| (IV) | 14850 | 7-hydroxy-2,2,4,6-tetramethyl-1-indanone oxime | C13H17NO2 | 详情 | 详情 | |
| (V) | 14851 | 3-amino-2,2,5,7-tetramethyl-4-indanol | C13H19NO | 详情 | 详情 | |
| (VI) | 14852 | 2-chloro-N-(7-hydroxy-2,2,4,6-tetramethyl-2,3-dihydro-1H-inden-1-yl)acetamide | C15H20ClNO2 | 详情 | 详情 | |
| (VII) | 14853 | methyl 3-piperazinophenyl ether; 1-(3-methoxyphenyl)piperazine | 16015-71-7 | C11H16N2O | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号：(II)The title amide is prepared by coupling between 9-acridinecarboxylic acid (I) and N-(3-methoxyphenyl)piperazine (II) in the presence of PyBOP and NMM
| 【1】 Emig, P.; Gunther, E.; Beckers, T.; Baasner, S.; Bcher, G.; Aue, B. (Zentaris AG); Novel heteroaryl derivs. and the use thereof as pharmaceuticals. EP 1301485; WO 0208194 . |
合成路线3
该中间体在本合成路线中的序号：(VIII)Heck coupling of 2-bromo-6-fluoroaniline (I) with methyl acrylate (II) by means of Pd(oAc)2, (o-tol)3P and Et3n in refluxing acetonitrile yields the (E)-cinnamate (III), which is then treated with PPh3 in the presence of CCl4 and Et3n in acetonitrile to give the iminophosphorane (IV). Compound (IV) is then condensed with 2-methoxy-5-(trifluoromethyl) phenyl isocyanate (V) [prepared by treatment of 2-methoxy-5-(trifluoromethyl)aniline (VI) with diphosgene in the presence of proton sponge] in CH2Cl2 to provide the carbodiimide (VII). Cyclocondensation of carbodiimide (VII) with 1-(3-methoxyphenyl)-piperazine (VIII) in the presence of Sio2 in refluxing CH2Cl2 affords the 3,4-dihydroquinazoline derivative (IX) (1), which is then subjected to ester hydrolysis with naoH in H2o/dioxane to produce the racemic carboxylic acid (X) . Finally, racemate (X) is resolved through chiral HPLC .
In an alternative procedure, chlorination of the dihydroquinazolinone derivative (XI) with PoCl3 and DBU in refluxing chlorobenzene, followed by coupling of the resulting 2-chloro-3,4-dihydroquinazoline (XII) with 1-(3-methoxyphenyl)piperazine (VIII) in the presence of DBU in refluxing dioxane produces the 3,4-dihydroquinazoline derivative (IX). Resolution of the racemic ester (IX) using di-p-toluoyl-D-tartaric acid in EtoAc provides the corresponding (S)-enantiomer (XIII), which is finally hydrolyzed with naoH in H2O/dioxane .
| 【1】 Wunberg, T., Jeske, M., Lampe, T. et al. (Bayer HealthCare AG). Substituted dihydrochinazolines having antiviral properties. DE 10319612, EP 1622880, JP 2006525249, US 2005065160, US 7196086, US 2007191387, Wo 2004096778. |
| 【2】 Goossen, K., Kuhn, o., Berwe, M., Krueger, J., Militzer, H.-C. (Bayer HealthCare AG). Method for producing dihydroquinazolines. Cn 101863843, DE 10227517, EP 1893587, JP 2008543797, US 2009221822, US 8084604, US 2012130072, US 8372972, Wo 2006133822. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 68030 | 2-bromo-6-fluoroaniline | 65896-11-9 | C6H5BrFN | 详情 | 详情 |
| (II) | 14156 | methyl acrylate | 96-33-3 | C4H6O2 | 详情 | 详情 |
| (III) | 68031 | (E)-methyl 3-(2-amino-3-fluorophenyl)acrylate | C10H10FNO2 | 详情 | 详情 | |
| (IV) | 68032 | (E)-methyl 3-(3-fluoro-2-((triphenylphosphoranylidene)amino)phenyl)acrylate | C28H23FNO2P | 详情 | 详情 | |
| (V) | 68033 | 2-methoxy-5-(trifluoromethyl)phenyl isocyanate | 16588-75-3 | C9H6F3NO2 | 详情 | 详情 |
| (VI) | 27669 | 2-methoxy-5-(trifluoromethyl)aniline | 349-65-5 | C8H8F3NO | 详情 | 详情 |
| (VII) | 68034 | (E)-methyl 3-(3-fluoro-2-((((2-methoxy-4-(trifluoromethyl)phenyl)imino)methylene)amino)phenyl)acrylate | C19H14F4N2O3 | 详情 | 详情 | |
| (VIII) | 14853 | methyl 3-piperazinophenyl ether; 1-(3-methoxyphenyl)piperazine | 16015-71-7 | C11H16N2O | 详情 | 详情 |
| (IX) | 68035 | methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate | C30H30F4N4O4 | 详情 | 详情 | |
| (X) | 68036 | 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acid | C29H28F4N4O4 | 详情 | 详情 | |
| (XI) | 68037 | methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-oxo-1,2,3,4-tetrahydroquinazolin-4-yl)acetate | C19H16F4N2O4 | 详情 | 详情 | |
| (XII) | 68038 | methyl 2-(2-chloro-8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-3,4-dihydroquinazolin-4-yl)acetate | C19H15ClF4N2O3 | 详情 | 详情 | |
| (XIII) | 68039 | (S)-methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate | C30H30F4N4O4 | 详情 | 详情 |